Adverse effects of monoclonal antibodies in patients with multiple sclerosis: a real world experience

被引：0
|
作者：
Baklan, M. [1 ]
Tuncel, R. [1 ]
Ekmekci, O. [1 ]
Yuceyar, N. [1 ]
机构：
[1] Ege Univ Med Sch Hosp, Dept Neurol, Izmir, Turkey
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1586
引用
收藏
页码：881 / 881
页数：1
相关论文
共 50 条
  • [21] Monoclonal antibodies in the development of multiple sclerosis
    Sastre-Garriga, J.
    Montalban, X.
    NEUROLOGIA, 2011, 26 (09): : 556 - 562
  • [22] Vaccinations in patients with multiple sclerosis: a real-world, single-center, experience
    Sbragia, E.
    Olobardi, D.
    Giovanni, N.
    Lapucci, C.
    Boffa, G.
    Capello, E.
    Cellerino, M.
    Laroni, A.
    Sticchi, L.
    Inglese, M.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 648 - 649
  • [23] Vaccinations in patients with multiple sclerosis: a real-world, single-center, experience
    Sbragia, E.
    Olobardi, D.
    Novi, G.
    Lapucci, C.
    Cellerino, M.
    Boffa, G.
    Laroni, A.
    Mikulska, M.
    Sticchi, L.
    Inglese, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 788 - 788
  • [24] Real-world experience of secondary progressive multiple sclerosis patients treated with siponimod
    Totaro, Rocco
    Borriello, Giovanna
    Marinelli, Fabiana
    Bianco, Assunta
    Evangelista, Luana
    Mirabella, Massimiliano
    Cicia, Alessandra
    Marini, Carmine
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1240 - 1241
  • [25] Vaccinations in patients with multiple sclerosis: a real-world, single-center experience
    Sbragia, Elvira
    Olobardi, Dario
    Novi, Giovanni
    Lapucci, Caterina
    Cellerino, Maria
    Boffa, Giacomo
    Laroni, Alice
    Mikulska, Malgorzata
    Sticchi, Laura
    Inglese, Matilde
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (06)
  • [26] Real world study of ocrelizumab in multiple sclerosis: Kuwait experience
    Alroughani, Raed
    Almojel, Malak
    Al-Hashel, Jasem
    Ahmed, Samar Farouk
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 79
  • [27] REAL WORLD EXPERIENCE OF FINGOLIMOD IN MULTIPLE SCLEROSIS: THE LONDON AUDIT
    Stavrou, Maria
    Smith, Deborah
    Shaw, Pauline
    Raciborska, Dominika
    Silber, Eli
    Brex, Peter
    Giovannoni, Gavin
    Schmierer, Klaus
    Turner, Benjamin
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 (12):
  • [28] Real world experience with cladribine tablets for multiple sclerosis at four academic multiple sclerosis centers
    Conway, Devon S.
    Nicholas, Jacqueline A.
    Thompson, Nicolas R.
    Mowry, Ellen M.
    Naismith, Robert T.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2025, 94
  • [29] Real world experience after one year of treatment with antiCGRP monoclonal antibodies in patients with chronic migraine
    Gonzalez-Quintanilla, V.
    Madera Fernandez, J.
    Garate, G.
    Perez-Pereda, S.
    Pascual Gomez, J.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [30] Efficacy and safety of ocrelizumab in patients with relapsing multiple sclerosis: Real-world experience of two Swiss multiple sclerosis centers
    Diem, L.
    Ovchinnikov, A.
    Friedli, C.
    Hammer, H.
    Kamber, N.
    Chan, A.
    Salmen, A.
    Findling, O.
    Hoepner, R.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 86
12345